The levels of cholesterol and apoA-I in plasma HDL have been known to be low in patients with Alzheimer's disease, suggesting that high levels of apoA-I/HDL reduce the risk of cardiovascular disease. The gene discussed is APOA1; the disease is cardiovascular disorder.